Latest:
Dr Tan on the Implications of Data From an Analysis of the PDIGREE Trial for Dual Checkpoint Blockade in ccRCC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Latest:
Dr Tan on the Implications of Data From an Analysis of the PDIGREE Trial for Dual Checkpoint Blockade in ccRCC
Latest:
Dr Koehne on the Evolution of the Multiple Myeloma Treatment Paradigm
Latest:
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer
Latest:
Dr. Efstathiou on the rPFS Benefit Achieved With Apalutamide Regimen in mCRPC
Latest:
Dr Villalona-Calero on the Investigation of KB-0742 in Relapsed/Refractory Solid Tumors
Latest:
Dr Swoboda on the Role of TKIs in Chronic Myeloid Leukemia
Latest:
Dr Kambhampati on the Rationale For Evaluating Real-World Outcomes With Brexu-Cel in MCL